{"text": "rt AT_USER $regn on praluent: len says $amgn is not caring about patients by not allowing a delay of the injunction. #jpm17"}
{"text": "rt AT_USER $regn on $amgn: it is no small wonder that our industry is not beloved. we say we put patients first, but... #jpm17"}
{"text": "rt AT_USER len asks if $amgn is going to do the \"right thing\" for patients when it comes to pcsk9 patent battle. #jpm17"}
{"text": "rt AT_USER $regn on praluent: len says $amgn is not caring about patients by not allowing a delay of the injunction. #jpm17"}
{"text": "len asks if $amgn is going to do the \"right thing\" for patients when it comes to pcsk9 patent battle. #jpm17"}
{"text": "$regn on $amgn: it is no small wonder that our industry is not beloved. we say we put patients first, but... #jpm17"}
{"text": "$regn on praluent: len says $amgn is not caring about patients by not allowing a delay of the injunction. #jpm17"}
{"text": "rt AT_USER $amgn 3 out of 4 repatha prescriptions rejected by us payers,how much will this change with cvot (tba in acc in march)?\u00a1\u00ad"}
{"text": "rt AT_USER $amgn will be \"judicious\" when it comes to price increases. \"that's what this time calls for\" - bradway"}
{"text": "rt AT_USER heads up $amgn URL"}
{"text": "heads up $amgn URL"}
{"text": "rt AT_USER i personally like gaps on nasdaq 100 stocks as support zones, as they are usually back filled $nvda $goog $googl $xbi $bii\u00a1\u00ad"}
{"text": "#amgen : statement on january 9, 2017, u.s. district court decision. read more: URL $amgn"}
{"text": "rt AT_USER $regn ceo len schleifer was sitting in on $amgn breakout session. he just walked out after bradway answered ? about inj\u00a1\u00ad"}
{"text": "$amgn pr - us district court denied sanofi's motion to stay the injunction URL"}
{"text": "$amgn sanofi and regeneron's motion to stay injunction pending appeal in ongoing pcsk9  patent litigation $regn $sny"}
{"text": "$amgn - amgen statement on january 9, 2017, u.s. district court decision URL"}
{"text": "rt AT_USER $regn ceo len schleifer was sitting in on $amgn breakout session. he just walked out after bradway answered ? about inj\u00a1\u00ad"}
{"text": "scan results - 180 bullish setup today: $clvs $nuan $once $amcx $cyno $amgn $plce $nvs $hrg $tgna ... URL"}
{"text": "rt AT_USER $regn ceo len schleifer was sitting in on $amgn breakout session. he just walked out after bradway answered ? about inj\u00a1\u00ad"}
{"text": "rt AT_USER $amgn 75% repatha rx rejected by payers, representing ~ $1b in revenue. #jpm17"}
{"text": "rt AT_USER $amgn will be \"judicious\" when it comes to price increases. \"that's what this time calls for\" - bradway"}
{"text": "rt AT_USER $amgn will be \"judicious\" when it comes to price increases. \"that's what this time calls for\" - bradway"}
{"text": "rt AT_USER $amgn will be \"judicious\" when it comes to price increases. \"that's what this time calls for\" - bradway"}
{"text": "rt AT_USER $amgn open to payer contracts that will let them \"put their money where their mouth is.\" ie: vbr contracts."}
{"text": "rt AT_USER $regn ceo len schleifer was sitting in on $amgn breakout session. he just walked out after bradway answered ? about inj\u00a1\u00ad"}
{"text": "$amgn will be \"judicious\" when it comes to price increases. \"that's what this time calls for\" - bradway"}
{"text": "rt AT_USER $amgn open to payer contracts that will let them \"put their money where their mouth is.\" ie: vbr contracts."}
{"text": "$amgn sum put vol=4,833 sum call vol=6,628 putcallratio=0.73 expiration 01/13/2017 . URL URL"}
{"text": "$amgn open to payer contracts that will let them \"put their money where their mouth is.\" ie: vbr contracts."}
{"text": "rt AT_USER more i-o: $amgn, immatics in $1b deal to broaden scope of bite technology"}
{"text": "rt AT_USER $amgn 75% repatha rx rejected by payers, representing ~ $1b in revenue. #jpm17"}
{"text": "adamfeuerstein: $regn ceo len schleifer was sitting in on $amgn breakout session. he just walked out after bradway answered ? about injunct\u00a1\u00ad"}
{"text": "adamfeuerstein: \"draconian utilization management criteria.\" -- $amgn on payer practices re: repatha. #jpm17"}
{"text": "adamfeuerstein: $amgn 75% repatha rx rejected by payers, representing ~ $1b in revenue. #jpm17"}
{"text": "rt AT_USER $regn ceo len schleifer was sitting in on $amgn breakout session. he just walked out after bradway answered ? about inj\u00a1\u00ad"}
{"text": "rt AT_USER $regn ceo len schleifer was sitting in on $amgn breakout session. he just walked out after bradway answered ? about inj\u00a1\u00ad"}
{"text": "rt AT_USER $regn ceo len schleifer was sitting in on $amgn breakout session. he just walked out after bradway answered ? about inj\u00a1\u00ad"}
{"text": "$regn ceo len schleifer was sitting in on $amgn breakout session. he just walked out after bradway answered ? about injunction. #jpm17"}
{"text": "rt AT_USER $amgn 75% repatha rx rejected by payers, representing ~ $1b in revenue. #jpm17"}
{"text": "rt AT_USER $amgn 75% repatha rx rejected by payers, representing ~ $1b in revenue. #jpm17"}
{"text": "rt AT_USER \"draconian utilization management criteria.\" -- $amgn on payer practices re: repatha. #jpm17"}
{"text": "rt AT_USER $amgn's bradway says 3 of 4 repatha scrips still beging rejected by payers."}
{"text": "rt AT_USER $amgn expects to benefit from corporate tax reform &gt; more money floating around &gt; more deals &gt; strong 2017 for pharma?\u00a1\u00ad"}
{"text": "draconian utilization management criteria.\" -- $amgn on payer practices re: repatha. #jpm17"}
{"text": "rt AT_USER $amgn 75% repatha rx rejected by payers, representing ~ $1b in revenue. #jpm17"}
{"text": "rt AT_USER $amgn 75% repatha rx rejected by payers, representing ~ $1b in revenue. #jpm17"}
{"text": "$amgn 75% repatha rx rejected by payers, representing ~ $1b in revenue. #jpm17"}
{"text": "navellier &amp; associates inc sells 678 shares of amgen inc. $amgn URL"}
{"text": "rt AT_USER $amgn's bradway says 3 of 4 repatha scrips still beging rejected by payers."}
{"text": "$amgn expects to benefit from corporate tax reform &gt; more money floating around &gt; more deals &gt; strong 2017 for pharma? #jpm17"}
{"text": "rt AT_USER $amgn's bradway says 3 of 4 repatha scrips still beging rejected by payers."}
{"text": "$amgn abo 215 (avastin biosimilar) filing expected in sept #jpm17"}
{"text": "amgen\u00a1\u00afs $amgn \u00a1\u00b0positive\u00a1\u00b1 rating reaffirmed at goldman sachs group, inc. $the URL"}
{"text": "$amgn's bradway says 3 of 4 repatha scrips still beging rejected by payers."}
{"text": "$amgn 3 out of 4 repatha prescriptions rejected by us payers,how much will this change with cvot (tba in acc in march)? #jpm17"}
{"text": "amgen $amgn shares went up 1.3% today after it announced $500m partnership w immatics to develop cancer drugs: URL"}
{"text": "AT_USER AT_USER AT_USER price increases help prove my case! thank you! $vrx $agn $srpt #jpm17 $iep $hlf\u00a1\u00ad URL"}
{"text": "AT_USER hey iggy im just shakin some bushes lol ,new pos in $amgn in at 146 looking real good $tgtx $fbio what u trading ?"}
{"text": "hot #biotechstocks to watch $amgn $ilum $ovas $gnvc #biotechshowcase #biotech #stocks #trading #investing #genes #stockmarket"}
{"text": "#amgen, immatics collaborate on bispecific cancer immunotherapies. read more: URL $amgn"}
{"text": "#amgen immatics enter strategic collaboration for novel bispecific cancer immunotherapies. read more: URL $amgn"}
{"text": "#amgen, immatics enter strategic collaboration for novel bispecific cancer immunotherapies. read more: URL $amgn"}
{"text": "new #biotech leaders: $amgn $biib $regn have scored huge runs. will incyte be the next? URL $incy #investing #stocks"}
{"text": "rt AT_USER 4 drug companies to consider selling URL $agn $nvs $amgn $lly"}
{"text": "4 drug companies to consider selling URL $agn $nvs $amgn $lly"}
{"text": "$dva bulls used to make case that $300-$400m in savings from $amgn esa would be on table ... but we get the guide down"}
{"text": "rt AT_USER more i-o: $amgn, immatics in $1b deal to broaden scope of bite technology"}
{"text": "#calithera pharma in focus, part 3 - arginase inhibitor and #acquisition target $cala also $gild $bmy $amgn $fprx URL"}
{"text": "rt AT_USER trending #biotech topics include $ions, $amgn, $jax #stocks #invest see more URL"}
{"text": "trending #biotech topics include $ions, $amgn, $jax #stocks #invest see more URL"}
{"text": "analyst activity \u00a8c bmo capital markets reiterates buy on amgen (nasdaq:amgn) URL $amgn"}
{"text": "3 investment themes emerging early in 2017 URL $amgn $m $sqbg URL"}
{"text": "rt AT_USER $amgn m&amp;a #jpm17 don\u00a1\u00aft feel constrained with respect to size,&amp;there are a lot more small&amp;early opportunities than large and\u00a1\u00ad"}
{"text": "analyst activity \u00a8c bmo capital markets reiterates buy on amgen (nasdaq:amgn) URL $amgn"}
{"text": "$amgn m&amp;a #jpm17 don\u00a1\u00aft feel constrained with respect to size,&amp;there are a lot more small&amp;early opportunities than large and late right now."}
{"text": "analyst activity \u00a8c bmo capital markets reiterates buy on amgen (nasdaq:amgn) URL $amgn"}
{"text": "more i-o: $amgn, immatics in $1b deal to broaden scope of bite technology"}
{"text": "#amgen and immatics enter strategic collaboration to develop novel bispecific cancer immuno... read more: URL $amgn"}
{"text": "$amgn #amgen wins permanent injunction against praluent - URL"}
{"text": "$amgn oi for maturity 01/13/2017. 152.50 highest put. 160.00 highest call. URL URL"}
{"text": "these 3 ugly patent battles could rock biopharma's 2017 $amgn $sny $regn $mrk $gild $nvs URL"}
{"text": "icymi: {video} biotech analysis + trade ideas! $ibb $biib $regn $amgn $agn $celg $gild $myl URL"}
{"text": "the market may surprise traders, but will $amgn? URL URL"}
{"text": "biotech preview for 2017. small cap should be a big winner. $amgn $gild $celg $agn $ibb $azn $regn $bax $incy URL"}
{"text": "how to get drugs into the #cns. $amgn $gild $celg $agn $abt $azn $regn $bax $incy URL"}
{"text": "bioasis video interview with the ceo. cash flowing in 2017...what??? $amgn $gild $celg $agn $abt $azn $regn $bax URL \u00a1\u00ad"}
{"text": "morning coffee - cgwm (feat. $eld, $jag, $pjc, $ppy, $pli, $tho, $tos, $amgn, $aapl, $regn, $sbux, $vz, $v, etc.) URL"}
{"text": "#amgen, immatics in next-gen immunotherapy alliance. read more: URL $amgn"}
{"text": "why the #amgen/regeneron patent saga is far from over. read more: URL $amgn"}
{"text": "... expected immediately. $amgn noted that if all written scripts were filled today, repatha would be a \"billion dollar\" business. (sayed)"}
{"text": "amgen bought another german oncology company, micromet, in $1.16b transaction in 2012. $amgn URL"}
{"text": "mizuho analyst salim sayed on $amgn repatha: company believes utilization will increase once cvot data in label. label update likely in 2018"}
{"text": "amgen teams up with germany's immatics biotech in immuno-oncology $amgn URL"}
{"text": "$amgn, $amgn technical alert: amgen matches friday's low and rebounds - URL"}
{"text": "rt AT_USER how to trade stocks with short-term gain catalysts and longer-term growth potential: URL $amgn $csx $eba\u00a1\u00ad"}
{"text": "amgn top news - jan 9th, 2017 $amgn URL"}
{"text": "benzinga: why the amgen/regeneron patent saga is far from over URL $amgn $regn $sny"}
{"text": "why the amgen/regeneron patent saga is far from over URL $amgn $regn $sny"}
{"text": "marketcurrents: amgen teams up with germany's immatics biotech in immuno-oncology URL $amgn"}
